Meta Health Limited (SGX: 5DX)
Singapore
· Delayed Price · Currency is SGD 0.0090
0.00 (0.00%)
At close: Sep 12, 2024
Meta Health Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.63 | -8.41 | -8.66 | 1.16 | -1.96 | 0.2 | Upgrade
|
| Depreciation & Amortization | 0.58 | 1.53 | 2.63 | 2.8 | 2.87 | 3.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.2 | 3.91 | -0.17 | -9.83 | -0.08 | -0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.16 | 0.16 | 0.12 | 7.74 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | 0.63 | 0.45 | - | 0.05 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.48 | 0.43 | 1.72 | -0.02 | -0 | 0.02 | Upgrade
|
| Other Operating Activities | 5.01 | 5.48 | 1.74 | 0.61 | 0.42 | 0.58 | Upgrade
|
| Change in Accounts Receivable | 0.39 | 0.1 | 2.75 | -1.74 | 0.01 | 2.06 | Upgrade
|
| Change in Inventory | 0.29 | 0.52 | 0.88 | -0.74 | -0.09 | 0.83 | Upgrade
|
| Change in Accounts Payable | -2.87 | -1.39 | -2.66 | -0.6 | -1.03 | -0.5 | Upgrade
|
| Change in Unearned Revenue | -0.02 | 0.05 | -0.12 | -0.14 | -0.54 | 0.08 | Upgrade
|
| Change in Other Net Operating Assets | 0.62 | 0.37 | 0.13 | 0.6 | 0.88 | -0.52 | Upgrade
|
| Operating Cash Flow | -2.43 | -2.24 | -2.25 | 0.29 | 0.48 | 5.85 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -39.49% | -91.83% | - | Upgrade
|
| Capital Expenditures | -0.28 | -0.41 | -0.49 | -0.37 | -0.39 | -1.54 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.5 | 0.63 | 1.03 | 0.03 | 0.14 | 0.18 | Upgrade
|
| Cash Acquisitions | 0.01 | -0.06 | - | -3.76 | - | - | Upgrade
|
| Divestitures | 4.63 | 4.53 | - | 8.71 | 4.75 | - | Upgrade
|
| Investment in Securities | - | - | -0.2 | -1.44 | - | - | Upgrade
|
| Other Investing Activities | 0 | 0.01 | -2.59 | 0.03 | 0.01 | -1.18 | Upgrade
|
| Investing Cash Flow | 4.86 | 4.7 | -2.25 | 3.19 | 4.51 | -2.54 | Upgrade
|
| Long-Term Debt Issued | - | 5.26 | 9.27 | 6.25 | 15.12 | 25.13 | Upgrade
|
| Total Debt Issued | 2.37 | 5.26 | 9.27 | 6.25 | 15.12 | 25.13 | Upgrade
|
| Long-Term Debt Repaid | - | -7.64 | -10.76 | -8.32 | -17.7 | -27.81 | Upgrade
|
| Total Debt Repaid | -5.71 | -7.64 | -10.76 | -8.32 | -17.7 | -27.81 | Upgrade
|
| Net Debt Issued (Repaid) | -3.34 | -2.38 | -1.48 | -2.08 | -2.59 | -2.69 | Upgrade
|
| Issuance of Common Stock | 2.49 | 2.49 | - | 5 | - | - | Upgrade
|
| Other Financing Activities | -0.3 | -0.39 | -0.82 | -0.45 | -0.43 | -0.59 | Upgrade
|
| Financing Cash Flow | -1.16 | -0.28 | -2.3 | 2.48 | -3.02 | -3.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.11 | -0.23 | -0.14 | 0.02 | 0.03 | 0.02 | Upgrade
|
| Net Cash Flow | 1.16 | 1.95 | -6.94 | 5.97 | 2 | 0.06 | Upgrade
|
| Free Cash Flow | -2.71 | -2.65 | -2.74 | -0.08 | 0.08 | 4.31 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -98.05% | - | Upgrade
|
| Free Cash Flow Margin | -182.91% | -57.46% | -24.07% | -0.19% | 0.26% | 9.48% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.01 | Upgrade
|
| Cash Interest Paid | 0.3 | 0.39 | 0.53 | 0.45 | 0.43 | 0.69 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.03 | - | 0 | -0 | Upgrade
|
| Levered Free Cash Flow | 1.76 | 1.75 | -0.55 | 9.08 | -4.82 | 3.22 | Upgrade
|
| Unlevered Free Cash Flow | 1.92 | 1.93 | -0.38 | 9.39 | -4.55 | 3.65 | Upgrade
|
| Change in Net Working Capital | -2.36 | -2.57 | 0.15 | -6.53 | 6.09 | -1.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.